PYC Therapeutics

PYC Therapeutics is a brand that combines world-leading RNA therapeutics design with revolutionary delivery technology to help cure inherited diseases. They are at the forefront of life-changing science, aiming to solve the delivery challenge that has hindered the potential of RNA therapeutics. By leveraging a proprietary library of naturally derived Cell Penetrating Peptides (CPPs), PYC Therapeutics ensures efficient and safe delivery of therapeutic cargo into target cells.

The brand is dedicated to changing the lives of patients with inherited diseases by developing a pipeline of highly precise RNA therapeutics. They utilize the latest generation of Antisense Oligonucleotides known as Phosphorodiamidate Morpholino Oligomers (PMOs) to safely and effectively deliver therapies to target cells. Currently, they have three peptide conjugated PMOs in preclinical development, focusing on inherited ocular diseases with high unmet needs.

Additionally, PYC Therapeutics is expanding their pipeline to include therapies for ocular and important neurodegenerative diseases. With a passionate and united team, PYC Therapeutics is pioneering a new generation of RNA therapeutics. They are driven by the urgency to provide treatment options for patients with inherited diseases.

Stay connected with PYC Therapeutics to witness their groundbreaking advancements in the field of RNA therapeutics